Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
XHQLX:US
NASDAQ GM
29.07
USD
0.05
0.17%
As of 09:29:30 ET on 07/02/2015.
Volume
0
Previous Close
29.02
52Wk Range
21.18 - 29.72
1 Yr Return
36.71%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
29.07
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Last Dividend (on 05/22/2015)
0.54
Dividend Indicated Gross Yield
7.43%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
1.05%
Expense Ratio
1.32%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 563.82 k 60.02 m 13.52
Celgene Corp 436.32 k 41.35 m 9.31
Vertex Pharmaceuticals Inc 206.56 k 23.20 m 5.22
Alexion Pharmaceuticals Inc 127.80 k 21.19 m 4.77
Regeneron Pharmaceuticals Inc 54.52 k 19.66 m 4.43
Amgen Inc 136.59 k 19.19 m 4.32
Biogen Inc 54.18 k 17.92 m 4.04
Incyte Corp 259.92 k 12.75 m 2.87
Allergan plc 46.82 k 11.30 m 2.54
Shire PLC 37.38 k 9.68 m 2.18
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500